 SHELTON, CT ACCESSWIRE May 17, 2021 NanoViricides, Inc. NYSE American:NNVC the Company a global leader in the development of highly effective antiviral therapies based on a novel nanomedicines platform the Company, has filed its quarterly report for its third quarter of financial year 2021 with the Securities and Exchange Commission. This press release should be read in conjunction with the Companys Form 10-Q filed on May 14, 2021. 